Focus on alirocumab: A PCSK9 antibody to treat hypercholesterolemia
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference43 articles.
1. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials;Mihaylova;Lancet,2012
2. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult;Anderson;Can. J. Cardiol.,2013
3. An international atherosclerosis society position paper: global recommendations for the management of dyslipidemia;Expert Dyslipidemia Panel;J. Clin. Lipidol.,2013
4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mapping genetic determinants of 184 circulating proteins in 26,494 individuals to connect proteins and diseases;2021-08-05
2. Hypercholesterolemia: The role of PCSK9;Archives of Biochemistry and Biophysics;2017-07
3. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons;Nutrition, Metabolism and Cardiovascular Diseases;2016-10
4. Lipids, blood pressure and kidney update 2015;Lipids in Health and Disease;2015-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3